You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Sofosbuvir–velpatasvir for treating chronic hepatitis C

  • Technology appraisal guidance
  • Reference number: TA430
  • Published:  25 January 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft guidance
  4. Draft scope documents
  5. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 240 KB)

    Published:
    25 January 2017

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 541 KB)

    Published:
    13 December 2016
  • Committee papers (PDF 1.5 MB)

    Published:
    13 December 2016
  • Committee papers Slides (PDF 824 KB)

    Published:
    13 December 2016

Draft guidance

  • Draft guidance

  • Committee papers (PDF 14.01 MB)

    Published:
    23 September 2016
  • Appraisal consultation document (PDF 378 KB)

    Published:
    23 September 2016
  • Committee papers Committee meeting slides (PDF 573 KB)

    Published:
    23 September 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 153 KB)

    Published:
    20 May 2016
  • Provisional matrix (pre-referral) (PDF 100 KB)

    Published:
    20 May 2016

Invitation to participate

  • Final scope (PDF 119 KB)

    Published:
    23 May 2016
  • Final matrix (PDF 103 KB)

    Published:
    23 May 2016
Back to top